1. Home
  2. LQDA vs SKYW Comparison

LQDA vs SKYW Comparison

Compare LQDA & SKYW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

LQDA

Liquidia Corporation

N/A

Current Price

$35.37

Market Cap

3.1B

Sector

Health Care

ML Signal

N/A

Logo SkyWest Inc.

SKYW

SkyWest Inc.

N/A

Current Price

$91.87

Market Cap

3.7B

ML Signal

N/A

Company Overview

Basic Information
Metric
LQDA
SKYW
Founded
2004
1972
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Air Freight/Delivery Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
3.1B
3.7B
IPO Year
2020
1994

Fundamental Metrics

Financial Performance
Metric
LQDA
SKYW
Price
$35.37
$91.87
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
11
4
Target Price
$41.00
$122.00
AVG Volume (30 Days)
1.4M
292.2K
Earning Date
03-05-2026
04-23-2026
Dividend Yield
N/A
N/A
EPS Growth
51.81
33.20
EPS
N/A
10.35
Revenue
$158,320,000.00
$2,971,963,000.00
Revenue This Year
$265.61
$8.47
Revenue Next Year
$62.82
$3.57
P/E Ratio
N/A
$8.87
Revenue Growth
1031.18
N/A
52 Week Low
$11.26
$74.70
52 Week High
$46.67
$123.94

Technical Indicators

Market Signals
Indicator
LQDA
SKYW
Relative Strength Index (RSI) 46.97 42.58
Support Level $31.75 $87.67
Resistance Level $36.07 $103.63
Average True Range (ATR) 2.07 3.05
MACD 0.12 -0.08
Stochastic Oscillator 48.17 42.02

Price Performance

Historical Comparison
LQDA
SKYW

About LQDA Liquidia Corporation

Liquidia Corp is a United States-based biopharmaceutical company focused on the development, manufacturing, and commercialization of products that address unmet patient needs, with the current focus directed towards the treatment of pulmonary hypertension (PH) and pulmonary hypertension associated with interstitial lung disease. It conducts research, development, and manufacturing of novel products by applying its proprietary PRINT technology, a particle engineering platform, to enable the precise production of uniform drug particles. Its product includes YUTREPIA (treprostinil) inhalation powder, for the treatment of pulmonary arterial hypertension. The company also generates revenue from the sale of Treprostinil Injection through an agreement between its subsidiary and the manufacturer.

About SKYW SkyWest Inc.

SkyWest Inc offers commercial air services in the United States, Canada, Mexico, and the Caribbean. Additionally, it leases aircraft to capable users to help generate revenue. SkyWest generally provides regional flights and utilizes smaller, lower-cost aircraft to carry passengers who book tickets through partner airlines. It partners with carriers to fly and operate aircraft for a fee and may use the carriers' brands and ground support to coordinate marketing and transport passengers. The company has two reportable segments: SkyWest Airlines and SWC, which generate maximum revenue, and SkyWest Leasing activities.

Share on Social Networks: